Correlation Between Telix Pharmaceuticals and Apogee Therapeutics,

Can any of the company-specific risk be diversified away by investing in both Telix Pharmaceuticals and Apogee Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Telix Pharmaceuticals and Apogee Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Telix Pharmaceuticals Limited and Apogee Therapeutics, Common, you can compare the effects of market volatilities on Telix Pharmaceuticals and Apogee Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Telix Pharmaceuticals with a short position of Apogee Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Telix Pharmaceuticals and Apogee Therapeutics,.

Diversification Opportunities for Telix Pharmaceuticals and Apogee Therapeutics,

0.15

Correlation Coefficient

Telix Pharmaceuticals  Apogee Therapeutics,

Average diversification

The 3 months correlation between Telix and Apogee is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Telix Pharmaceuticals Limited and Apogee Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apogee Therapeutics, and Telix Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Telix Pharmaceuticals Limited are associated (or correlated) with Apogee Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apogee Therapeutics, has no effect on the direction of Telix Pharmaceuticals i.e., Telix Pharmaceuticals and Apogee Therapeutics, go up and down completely randomly.

Pair Corralation between Telix Pharmaceuticals and Apogee Therapeutics,

Considering the 90-day investment horizon Telix Pharmaceuticals Limited is expected to generate 0.6 times more return on investment than Apogee Therapeutics,. However, Telix Pharmaceuticals Limited is 1.68 times less risky than Apogee Therapeutics,. It trades about 0.11 of its potential returns per unit of risk. Apogee Therapeutics, Common is currently generating about -0.1 per unit of risk. If you would invest  1,515  in Telix Pharmaceuticals Limited on October 25, 2024 and sell it today you would earn a total of  189.00  from holding Telix Pharmaceuticals Limited or generate 12.48% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	75.0%
Values	Daily Returns

Telix Pharmaceuticals Limited  vs.  Apogee Therapeutics, Common

Telix Pharmaceuticals

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Telix Pharmaceuticals Limited are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak essential indicators, Telix Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Apogee Therapeutics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Apogee Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Telix Pharmaceuticals and Apogee Therapeutics,

The main advantage of trading using opposite Telix Pharmaceuticals and Apogee Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Telix Pharmaceuticals position performs unexpectedly, Apogee Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apogee Therapeutics, will offset losses from the drop in Apogee Therapeutics,'s long position.

The idea behind Telix Pharmaceuticals Limited and Apogee Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.